Korean Chinese Japanese
  • Economy
  • Politics
  • Society
  • Securities
  • Real estate
  • Culture
  • Entertainment
  • Sports
  • Opinion
Korean Chinese Japanese
Economy Corporation Pharma & Bio
Society Politics IT·Science
Securities Real Estate Global
Opinion Entertainment Sports Culture
Video Auto in Golf in
PHARM EDAILY Market in TheBeLT
IT·Science
Technology

DIO Corporation Receives European MDR Certification for New Products ‘SICON · Prism X’

(Photo courtesy of DIO Corporation) DIO Corporation(039840)announced on the 23rd that its new products, “SICON” and “Prism X,” have obtained certification under the European Medical Device Regulat…
  • 2026-09-23 10:38:02
  • KIM SAE-MI
Technology

Onconic Administer First Dose of ‘Jacubo’ Injection in China’s Phase 3 Trial… Claims $1 Million Milestone Payment

Exterior view of Onconic Therapeutics Inc. Research Institute (Photo courtesy of Onconic Therapeutics Inc.) #Onconic Therapeutics Inc.’s new potassium-competitive acid blocker (P-CAB) drug, “Zasta…
  • 2026-09-23 10:24:02
  • KIM SAE-MI
Internet

Kakao Mobility's U.S. IPO Put on Hold… Kakao: "Only TPG's Stake Cannot Be Liquidated"

Kakao(035720)has put the brakes on the American Depositary Receipt (ADR) listing that TPG, the second-largest shareholder of Kakao Mobility, has been pursuing. The company determined that, under the c…
  • 2026-09-23 08:56:33
  • Lee So-Hyun
Technology

SkyLabs Hits Upper Price Limit on U.S. Interest; Orum Therapeutics Extends Its Decline [K-Bio Pulse]

SkyLabs Hits Upper Price Limit on U.S. Attention; Orum Therapeutics Extends SlideSouth Korea’s pharmaceutical and biotech sector saw notable movements on September 21, led by SkyLabs, which hit the up…
  • 2026-09-23 08:02:02
  • KIM SUNG-JIN
Technology

SkyLabs Rises on U.S. Attention… Orum Therapeutics, Inc. Falls for the Second Consecutive Day [Bio Spotlight]

On the 21st, in the pharmaceutical and biotech sector, #SkyLabs stood out the most, hitting the daily price limit after a nine-trading-day downtrend. SkyLabs is a digital healthcare company that manuf…
  • 2026-09-23 08:01:02
  • KIM SUNG-JIN
Internet

CJ LOGISTICS to Handle 200 Types of Goods… RealWorld Enhances Fingertip AI with ‘RLDX-2’

In logistics settings, robots handle over 200 types of fast-moving items using five fingers, just like humans. RealWorld is accelerating the development of a next-generation robot artificial intellige…
  • 2026-09-23 06:05:03
  • Shin Yeong-bin
Internet

"Put AI Behind the Scenes… Prioritize Human Experience"

"Keep AI behind the scenes."Chris Skis, Executive Director and CEO of the Global Association of the Exhibition Industry (UFI), introduced this approach to utilizing AI (artificial intelligence) in the…
  • 2026-09-23 05:00:05
  • LEE SEON-WOO
Technology

DuChemBio Co, LTD Holds 96.3% Share of Dementia Diagnostic Test Production Value… Highest in Three Years

It has been revealed that DuChemBio Co.,LTD.(176750)accounted for 96.3% of the domestic production value of radiopharmaceuticals used to diagnose Alzheimer’s disease last year. As domestic prescriptio…
  • 2026-09-22 18:22:02
  • NA EUN-KYUNG
Technology

JEIL PHARM to Invest 24.9 Billion Won to Expand Baekam Plant… Production Capacity to Increase by 71%

Exterior view of the solid dosage form production line at JEIL PHARM’s Baekam Plant (Photo: JEIL PHARM) JEIL PHARM(271980)is investing 24.9 billion won to expand production facilities at its Baeka…
  • 2026-09-22 17:53:02
  • KIM SAE-MI
Internet

Bae Kyung-hoon: “Naver Has Been Sharpening Its Knives”… ‘Frontier-Level’ Cybersecurity AI on the Way

Naver (NAVER(035420)) has set its sights on developing artificial intelligence (AI) for cybersecurity. The company aims to release a security-specialized AI model that goes beyond the government’s exp…
  • 2026-09-22 16:44:16
  • Shin Yeong-bin
prev 11 12 13 14 15 16 17 18 19 20 next

PHARM EDAILY

Shorts

EDAILY
  • 92, Tongil-ro, Jung-gu, Seoul, Korea
  • +82 2 3772 0114
  • webmaster@edaily.co.kr

※ This article has been translated using AI technology for the convenience of readers.

EDAILY provides this translation on an “as is” basis and makes no warranties, express or implied, regarding its accuracy, reliability, completeness, merchantability, or fitness for a particular purpose.
Due to the limitations of machine translation, the translated content may differ from the original Korean article. In the event of any discrepancy, the original Korean version shall prevail.
EDAILY shall not be liable for any loss or damage arising from the use of, or reliance on, the translated content.

© 2026 Copyrights by edaily. All Rights Reserved.
Korea China Japan
English